MIB1 assessment is usually performed via microscopic analysis of positive nuclei using manual counting [18] and reporting as the percentage of positive nuclei per 1000 cells or 10,000 cells subjectively observed in tumor cells, but not in endothelial cells. The gene discussed is MIB1; the disease is neoplasm.